AADI: Aadi Bioscience, Inc. Stock

by  •  • Comments Off on AADI: Aadi Bioscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 70.49
Enterprise Value ($M) 39.95
Book Value ($M) 68.87
Book Value / Share 2.79
Price / Book 1.02
NCAV ($M) 60.48
NCAV / Share 2.45
Price / NCAV 1.17

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.47
Return on Equity (ROE) -0.59

Liquidity (mrq)
Quick Ratio 4.54
Current Ratio 4.89

Balance Sheet (mrq) ($M)
Current Assets 77.31
Assets 85.70
Liabilities 16.83
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
8 days ago 13G/A Satter Muneer A
8 days ago 13G QVT Financial LP
8 days ago 13G/A EcoR1 Capital, LLC
02-04 13D/A BML Investment Partners, L.P.
01-29 13G Point72 Asset Management, L.P.
01-24 13D/A Acuta Capital Partners, Llc
12-23 13D/A Desai Neil
12-23 13D/A Avoro Capital Advisors LLC

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 25,579 108,763 23.52
2025-02-20 22,388 42,584 52.57
2025-02-19 42,737 97,486 43.84
2025-02-18 36,137 127,992 28.23

(click for more detail)

Similar Companies
ABEO – Abeona Therapeutics Inc. ABVC – ABVC BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io